Emergent Biosolutions, Inc.
Symbol: EBS (NYSE)
9.26
▲ (5.00%) 0.441
Company Description:
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Key Stats
- Today's Open: $8.77
- Today's High: $9.29
- Today's Low: $8.606
- Today's Volume: 568.95K
- Yesterday Close: $8.82
- Yesterday High: $9.1
- Yesterday Low: $8.775
- Yesterday Volume: 749.96K
- Last Min Volume: 1.24K
- Last Min High: $9.265
- Last Min Low: $9.251
- Last Min VWAP: $9.25614
Company Profile
- Name: Emergent Biosolutions, Inc.
- Website: https://www.emergentbiosolutions.com
- Listed Date: 2006-11-15
- Location: GAITHERSBURG, MD
- Market Status: Active
- CIK Number: 0001367644
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $470.56M
- Round Lot: 100
- Outstanding Shares: 53.35M
- Asset Type: CS
RECENT FILINGS FOR EBS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 8-K | View |
| 2025-09-05 | 8-K | View |
| 2025-08-18 | 4 | View |
| 2025-08-15 | EFFECT | View |
| 2025-08-15 | 144 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | CORRESP | View |
| 2025-08-13 | UPLOAD | View |
| 2025-08-12 | 144 | View |
| 2025-08-07 | S-3 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-15 | 4 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-05-28 | 4 | View |
Latest News on EBS